In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, including Macrolide-/Amikacin-Resistant Clinical Isolates. - Kim DH; Kim SY; Huh HJ; Lee NY; Koh WJ; Jhun BW (Antimicrobial agents and chemotherapy, 2023)